James Krell

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

Andrew Blauvelt, Kim Papp, Alice B. Gottlieb et al. · British Journal of Dermatology · 2019 · 172 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +15

Diffuse dermal angiomatosis: a variant of reactive cutaneous angioendotheliomatosis

James Krell, Ramón L. Sánchez, Alvin R. Solomon · Journal of Cutaneous Pathology · 1994 · 117 citations

Medicine, Dermatology, Pathology +17

Secukinumab improves patient‐reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo‐controlled clinical trials

Bruce Strober, Bárður Sigurgeirsson, Georg Popp et al. · International Journal of Dermatology · 2016 · 45 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

An open-label study evaluating the efficacy and tolerability of alefacept for the treatment of scalp psoriasis

James Krell, CANDI P. NELSON, Linda V. Spencer et al. · Journal of the American Academy of Dermatology · 2008 · 29 citations

Medicine, Dermatology, Pharmacotherapy +7

Lymphocyte enumeration: a comparison between a modified avidin-biotin-immunoperoxidase system and flow cytometry.

Irvin L. Paradis, E J Merrall, James Krell et al. · Journal of Histochemistry & Cytochemistry · 1984 · 27 citations

Life Sciences, Cell Biology, Immunology +14